CompoAtlas

Curcuflex

Food supplement declared in France, declaration No 2020-10-934

Curcuflex (Dexsil) is a food supplement declared in France. Status: retiré du marché le 27 December 2021. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Dexsil
Food business operator placing the product on the market
BIOXYDIET FRANCE SAS
Status
Retiré du marché le 27 December 2021
Form
Capsule
Daily dose
1 capsule
Directions for use
1 capsule par jour avec un verre d'eau.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Problèmes de foie, Sous anticoagulants, Sous traitement médicamenteux
Objectives stated by the manufacturer (these are not authorised claims)
Os, Articulations

Declaration 305274, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Curcuma longa L.RhizomeOléorésine et gomme-oléorésine550 mg

Other active ingredients

NamePer day
Triglycérides à chaine moyennenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)

Additives

E433, E464, E307

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consultez votre médecin ou votre pharmacien en cas d’usage concomitant d’anticoagulants. Ne pas utiliser chez les femmes enceintes et allaitantes ni chez les enfants de moins de 18 ans, ni en cas de troubles du foie ou de la vésicule ou lors d’une prise concomitante d'autres médicaments.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Dexsil

Enter to analyse, Shift+Enter for a new line